Skip to main content

Advertisement

Open Access
Open Peer Review

This article has Open Peer Review reports available.

How does Open Peer Review work?

Gene-guided Gefitinib switch maintenance therapy for patients with advanced EGFR mutation-positive Non-small cell lung cancer: an economic analysis

  • Jun Zhu1,
  • Te Li1,
  • Xiaohui Wang2,
  • Ming Ye3,
  • Jian Cai4,
  • Yuejuan Xu5 and
  • Bin Wu6Email author
BMC Cancer201313:39

DOI: 10.1186/1471-2407-13-39

Received: 30 May 2012

Accepted: 16 January 2013

Published: 29 January 2013

Back to article

Open Peer Review reports

Pre-publication versions of this article and author comments to reviewers are available by contacting info@biomedcentral.com.

Original Submission
30 May 2012 Submitted Original manuscript
Resubmission - Version 2
Submitted Manuscript version 2
13 Jul 2012 Reviewed Reviewer Report - Gilberto de Lima Lopes
8 Sep 2012 Reviewed Reviewer Report - Li Zhang
11 Sep 2012 Reviewed Reviewer Report - Eric Finkelstein
2 Nov 2012 Author responded Author comments - Bin Wu
Resubmission - Version 3
2 Nov 2012 Submitted Manuscript version 3
2 Nov 2012 Author responded Author comments - Bin Wu
Resubmission - Version 4
2 Nov 2012 Submitted Manuscript version 4
14 Nov 2012 Reviewed Reviewer Report - Eric Finkelstein
12 Dec 2012 Author responded Author comments - Bin Wu
Resubmission - Version 5
12 Dec 2012 Submitted Manuscript version 5
Publishing
16 Jan 2013 Editorially accepted
29 Jan 2013 Article published 10.1186/1471-2407-13-39

How does Open Peer Review work?

Open peer review is a system where authors know who the reviewers are, and the reviewers know who the authors are. If the manuscript is accepted, the named reviewer reports are published alongside the article. Pre-publication versions of the article and author comments to reviewers are available by contacting info@biomedcentral.com. All previous versions of the manuscript and all author responses to the reviewers are also available.

You can find further information about the peer review system here.

Authors’ Affiliations

(1)
Department of Pharmacy, Shanghai Chest Hospital, affiliated with the School of Medicine, Shanghai Jiaotong University
(2)
Department of Pharmacy, Yuxi People’s Hospital, affiliated with the Kunming Medical College
(3)
Department of Clinical Oncology, Renji Hospital, affiliated with the School of Medicine, Shanghai Jiaotong University
(4)
Department of Clinical Oncology, Taixing People’s Hospital, affiliated with the School of Medicine, Yangzhou University
(5)
Department of Clinical Oncology, the Second Hospital of Nanjing, affiliated with the Medical School of South East University
(6)
Medical Decision and Economic Group, Department of Pharmacy, Renji Hospital, affiliated with the School of Medicine, Shanghai Jiaotong University

Advertisement